New Delhi, Feb. 13 -- Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, has executed the transaction definitive agreements with Pierre Fabre SA, and its affiliate entities, for JBIRSPL to acquire 80 percent equity capital in JASMIN (new company incorporated by PF in France), with remaining 20 percent retained by PF.
At closing of the transaction, JASMIN shall acquire Pierre Fabre's R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders' Agreement and other transition agreements with PF.
This strategic agreement will enable Jubilant Biosys Limited to expand its footprint in Europe in areas lik...